Benign — Non-Cancerous Growths and Conditions

A benign tumour consists of cells that resemble normal tissue and remain confined to their original site. Unlike malignant neoplasms, benign growths typically expand slowly and are often encased within a fibrous capsule. This structural boundary prevents individual cells from detaching, entering blood vessels or lymphatic channels, and establishing secondary growths elsewhere.

Although non-cancerous, certain benign tumours require clinical intervention. As they enlarge, they can compress adjacent organs, pinch nerves, impede fluid circulation, or produce excess hormones. Pathologists determine whether a lesion is benign through microscopic examination, assessing cellular architecture, nuclear features, and the absence of tissue invasion.

Receiving a benign diagnosis is generally positive news, significantly altering the trajectory of medical care. It typically removes the need for intensive cancer treatments such as systemic chemotherapy or radiotherapy. However, patients must understand that benign does not always mean no treatment is needed. Understanding the precise nature of the growth allows individuals to participate in shared decision-making regarding whether to remove the mass, manage symptoms with medication, or adopt an active surveillance approach with routine imaging scans.

Benign status is confirmed primarily through histopathology following a biopsy or surgical excision. Pathologists review cell morphology, mitotic rates, and tissue margins. Immunohistochemistry may be used to verify the absence of malignant markers. Diagnostic imaging, including ultrasound, magnetic resonance imaging (MRI), and computed tomography (PET or CT), helps characterise physical features such as smooth margins, which often suggest non-malignant behaviour.

The term benign arises across all medical disciplines, particularly during investigations for breast, prostate, skin, thyroid, and bowel cancers. For instance, fibroadenomas are common benign breast lumps, and benign prostatic hyperplasia frequently mimics prostate cancer symptoms. Benign melanocytic naevi (moles) are assessed to exclude melanoma, whilst benign polyps in the colon are monitored or removed to prevent malignant transformation.

Benign conditions rarely involve cytotoxic chemotherapy or radiation. Treatment focuses on symptom relief and risk prevention. If a benign tumour causes pain, functional impairment, or cosmetic concern, surgical resection is the primary intervention. In many cases, no intervention is needed beyond watchful waiting. Certain benign lesions with premalignant potential, like adenomatous polyps, are routinely excised during endoscopy to eliminate future cancer risk.